Loading clinical trials...
Loading clinical trials...
Rectal cancer is one of the most prevalent malignancies in the world, and its prevalence is rising. In more advanced cases neoadjuvant therapy is advised before to surgery, and radiotherapy is one of ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tehran University of Medical Sciences
NCT04703101 · Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, and more
NCT06312982 · Locally Advanced Rectal Carcinoma
NCT05245786 · Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, and more
NCT06276686 · Locally Advanced Rectal Carcinoma
NCT05772923 · Organ Preservation, Rectal Cancer, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions